Publicaciones en las que colabora con Pedro Javier Barroso Chinea (22)

2021

  1. Prolonged dopamine D3 receptor stimulation promotes dopamine transporter ubiquitination and degradation through a PKC-dependent mechanism

    Pharmacological Research, Vol. 165

2020

  1. DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis

    Autophagy, Vol. 16, Núm. 7, pp. 1279-1295

2018

  1. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease

    Experimental Neurology, Vol. 299, pp. 137-147

2016

  1. A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses

    Molecular Therapy - Methods and Clinical Development, Vol. 3, pp. 16027

  2. Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system

    Neurobiology of Disease, Vol. 88, pp. 44-54

2015

  1. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake

    Neurobiology of Disease, Vol. 74, pp. 325-335

2014

  1. Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons

    Frontiers in Neuroanatomy, Vol. 8, Núm. AUG

2010

  1. The dopamine transporter is differentially regulated after dopaminergic lesion

    Neurobiology of Disease, Vol. 40, Núm. 3, pp. 518-530

2007

  1. Aging of the rat mesostriatal system: Differences between the nigrostriatal and the mesolimbic compartments

    Experimental Neurology, Vol. 204, Núm. 1, pp. 147-161

2006

  1. Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats

    European Journal of Neuroscience, Vol. 23, Núm. 8, pp. 2099-2108

  2. Interleukin-6 and nitric oxide synthase expression in the vasopressin and corticotrophin-releasing factor systems of the rat hypothalamus

    Journal of Histochemistry and Cytochemistry, Vol. 54, Núm. 4, pp. 427-441

  3. Tetrahydrobiopterin stimulates l-DOPA release from striatal tissue

    European Journal of Pharmacology, Vol. 541, Núm. 1-2, pp. 33-37

2005

  1. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells

    European Journal of Neuroscience, Vol. 21, Núm. 7, pp. 1815-1827

2004

  1. Effect of intracerebroventricular injection of lipopolysaccharide on the tuberoinfundibular dopaminergic system of the rat

    Neuroscience, Vol. 127, Núm. 1, pp. 251-259

  2. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons

    Journal of Comparative Neurology, Vol. 479, Núm. 2, pp. 198-215

  3. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat

    Movement Disorders, Vol. 19, Núm. 9, pp. 1029-1042

2003

  1. Effects of dopaminergic cell degeneration on electrophysiological characteristics and GAD65/GAD67 expression in the substantia nigra: Different action on GABA cell subpopulations

    Movement Disorders, Vol. 18, Núm. 3, pp. 254-266

2002

  1. Response of GABAergic cells in the deep mesencephalic nucleus to dopaminergic cell degeneration: An electrophysiological and in situ hybridization study

    Neuroscience, Vol. 113, Núm. 2, pp. 311-321

2001

  1. Colocalization of tyrosine hydroxylase and GAD65 mRNA in mesostriatal neurons

    European Journal of Neuroscience, Vol. 13, Núm. 1, pp. 57-67

  2. Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: Similarities with cell loss in Parkinson's disease

    Experimental Neurology, Vol. 169, Núm. 1, pp. 163-181